ENVISIA THERAPEUTICS ANNOUNCES PANEL PRESENTATION AT UPCOMING CITI’S 11th ANNUAL BIOTECH CONFERENCE

ENVISIA THERAPEUTICS ANNOUNCES PANEL PRESENTATION AT UPCOMING CITI’S 11th ANNUAL BIOTECH CONFERENCE

RESEARCH TRIANGLE PARK, NCSeptember 1, 2016 – Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalmology, announced today that Dr. Benjamin Yerxa will participate in a panel titled “Emerging Innovators – An Introduction to Private Biotech Companies” at Citi’s 11th Annual Biotech Conference in Boston, MA on Thursday, September 8, 2016.  Read more here.

Copyright 2013 Envisia Therapeutics